Drug stocks have been out of favor due to regulatory concerns. Nevertheless, several top-tier stock experts and contributors to MoneyShow.com see select opportunities for long-term value investors to consider buying large cap pharmaceutical names.
Out-of-Favor Drugs Stocks May be the Right Medicine For Your Portfolio
